| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q3 2022 Pre-Market | EPS: REV: | 0.58 360.872M | |||
| Q2 2022 Pre-Market | EPS: REV: | 0.29 303.465M | |||
| Q1 2022 Pre-Market | EPS: REV: | 0.15 310.208M | |||
| Q4 2021 Pre-Market | EPS: REV: | 0.02 350.964M | |||
| Q3 2021 Pre-Market | EPS: REV: | 0.44 360.936M | 0.35 329.34M | 0.58 360.872M | 65.71% 9.57% |
| Q2 2021 Pre-Market | EPS: REV: | 0.31 314.981M | -0.01 266.92M | 0.29 303.465M | 3000% 13.69% |
| Q1 2021 Pre-Market | EPS: REV: | 0.02 278.292M | -0.12 251.05M | 0.15 310.208M | 225% 23.56% |
| Q4 2020 Pre-Market | EPS: REV: | -0.04 359.647M | 0.01 362.5M | 0.02 350.964M | 100% -3.18% |
| Q3 2020 Pre-Market | EPS: REV: | 0.49 363.649M | 0.47 373.65M | 0.44 360.936M | -6.38% -3.4% |
| Q2 2020 Pre-Market | EPS: REV: | 0.28 299.891M | 0.32 316M | 0.31 314.981M | -3.12% -0.32% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- 7 Stocks To Watch For March 1, 2021
- Earnings Scheduled For March 1, 2021
- RBC: Keurig Dr Pepper Growth 'Gets Another Jolt', 'Monster' Results From Monster Beverage
- The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
- Warren Buffett In Annual Letter Signals More Stock Buybacks Coming This Year, Says Don't 'Bet Against America'
- 4 Workday Analysts Break Down Earnings, Look Ahead To Fiscal 2022
- Rocket Companies 'Firing On All Cylinders,' BofA Says After Q4 Print
- Will Nio's Sagging Stock Get a Lift From Earnings? A Q4 Preview
- PreMarket Prep Stock Of The Day: DoorDash
- Mid-Afternoon Market Update: Crude Oil Down Over 3%; AMC Networks Shares Surge After Q4 Results
